In 2026, the independent broker/dealer channel will be shaped by more consolidation, artificial intelligence and a continued ...
Investor's Business Daily on MSN
DBV launches, up as much as 46%, on a new approach to peanut allergy
Shares of DBV Technologies launched Wednesday after the company reported promising results for its peanut allergy treatment.
Scientists have discovered that gut-born bacteria may hold the secret for treatments of everything from IBD to Parkinson’s ...
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, ...
Discusses Year-End Late-Stage Pipeline Review With Focus on Clinical and Regulatory Developments December 16, 2025 11:15 AM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback